Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Sep;105(38):655; author reply 655-6.
doi: 10.3238/arztebl.2008.0655. Epub 2008 Sep 19.

Gemcitabine more useful

Michael Geibler
Comment

Gemcitabine more useful

Michael Geibler. Dtsch Arztebl Int. 2008 Sep.
No abstract available

PubMed Disclaimer

Comment on

  • Pancreatic cancer--low survival rates.
    Beger HG, Rau B, Gansauge F, Leder G, Schwarz M, Poch B. Beger HG, et al. Dtsch Arztebl Int. 2008 Apr;105(14):255-62. doi: 10.3238/arztebl.2008.0255. Epub 2008 Apr 4. Dtsch Arztebl Int. 2008. PMID: 19629206 Free PMC article.

References

    1. Neoptolemos JP, Stocken DD, Firess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–1210. - PubMed
    1. Oettle H, Post S, Neuhaus P, Gelldorf K, et al. Adjuvant chemotherapy with Gemzitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. JAMA. 2007;297:267–77. Update ASCO 2008. - PubMed
    1. Adler G, Seufferlein T, Bischoff SC, et al. S3-Leitlinien „Exokrines Pankreaskarzinom“ 2007. Ergebnis einer evidenzbasierten Konsensuskonferenz. Gastroenterologie. 2007;6:487–523. - PubMed
    1. Stocken DD, Büchler MW, Dervenis C, et al. Pancreatic cancer Meta-analysis Group. Meta-analysis of randomized adjuvant therapy trials for pancreatic cancer. BJC. 2005;92:1372–1381. - PMC - PubMed